Eli Lilly's GLP-1 pill gets important support in Europe for helping with obesity and diabetes.

Oct 16, 2026, 11:07 AM ETTrialRead the original at Benzinga

Good for LLY

A European committee recommended Lilly’s pill for diabetes and weight management, and the report describes benefits for blood sugar and body weight. Final marketing permission is not reported, and stomach problems are common, but the recommendation supports Lilly’s outlook.

LLY · Eli Lilly and Co.

AI read · Good for LLY

The AI's read

This could give Eli Lilly another treatment for people with type 2 diabetes and obesity. The report says it helps control blood sugar and supports weight loss. Nausea, vomiting, and diarrhea are common side effects. The committee recommendation is encouraging, but it is not final marketing permission.

Get alerts for LLY

Follow Eli Lilly and Co. (LLY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LLY

Free on the App Store and Google Play, or on the web.